SIF guide
SIF due-diligence checklist
A seven-gate, evidence-first review that shows when a SIF can move forward, when research should pause, and when suitability should stop the process.
Key takeaway
Due diligence does not end with a score or a product name. It ends with one of three research states: continue with a complete dated evidence set, pause for a decision-critical gap, or stop because the strategy does not fit.
Worked due-diligence case
Seven gates before a SIF reaches the shortlist
Follow a fictional hybrid long-short SIF from product identity to performance context. The example is designed to show why a careful review can end with a pause even when much of the evidence looks good.
Fictional review candidate
Meridian Hybrid Long-Short Strategy
Illustrative name and evidence only. It does not represent a real SIF, an AMC view, or an investment recommendation.
- Intended role
- Diversified growth with active long-short positioning
- Capital considered
- Rs. 12 lakh of long-term investible surplus
- Review outcome
- Needs verification
Gate result
4 pass
3 pause
Four passed gates do not overrule three unresolved gates. Liquidity, operating evidence, and comparison quality can still change the decision, so the candidate does not move to an action list.
Due diligence is complete only when the unanswered questions are visible. A pause is a valid research result.
Pass
Enough exact evidence for this gate
Pause
One material fact still needs proof
Overall
The most important open gate controls
The seven-gate audit
Each gate asks one decision question
Identity
Is this the exact investment strategy?
The SIF brand, strategy name, code, plan, option, final ISID, and current addenda all point to the same record.
The product being reviewed is unambiguous.
Mandate
Can the portfolio job and permissions be explained?
The objective, asset-allocation ranges, permitted derivatives, benchmark, and long-short role have been read from the current ISID.
The mandate is understood beyond its product name.
Access and fit
Can the investor meet the access rule without straining liquidity?
The Rs. 10 lakh PAN-level SIF threshold, plan mechanics, concentration effect, and the investor's need for spare capital have been considered separately.
Eligibility is confirmed; personal suitability still requires judgment.
Risk and derivatives
Is the current risk evidence visible?
The latest dated Risk-band, derivative limits, scenario analysis, gross exposure, net exposure, and principal risk factors have been checked together.
The risk label is connected to the mechanics that can create loss.
Liquidity and exit
When and at what terms can money come out?
Redemption frequency and exit load are visible, but the latest notice-period position is not confirmed in a dated post-launch source.
A missing exit term can change whether the strategy fits the investor.
Operating evidence
Are manager, cost, size, and portfolio fields current?
The manager and portfolio are sourced, while plan-specific TER and the latest AUM still need exact dates and official locators.
The strategy can be studied, but the operating record is incomplete.
Performance context
Does the history support a fair comparison?
NAV history exists, but the common-date record is short and does not cover a full market cycle. Return and drawdown are treated as early observations.
The numbers describe observed behaviour, not repeatable skill.
Decision language
Continue, pause, and stop mean different things
These states govern the research process. None of them is a buy, sell, hold, suitability, or return forecast.
Continue research
The exact product and mandate are clear, suitability has not failed, and every decision-critical fact has a current official source.
Build the comparison and prepare questions for a qualified professional.
Pause
A current Risk-band, liquidity term, TER, manager, portfolio, tax classification, or common-date comparison remains missing or conflicting.
Record the gap and seek the exact source. Do not convert absence into an estimate.
Stop
The strategy role is not understood, the liquidity does not fit, the minimum commitment is not spare capital, or the risk is outside the investor's capacity.
Leave the product out of the shortlist. More performance data does not repair a fit failure.
Evidence packet
Four folders, one dated review
Keep every fact beside the document, locator, plan context, and date that supports it. A link without a field-level match is not enough.
Folder 1
Product identity
Final ISID, current SAI, later addenda, strategy code, plan, option, and ISIN where applicable.
Folder 2
Terms and risk
Risk-band and date, derivative scenario analysis, redemption frequency, notice period, exit load, and settlement timeline.
Folder 3
Current operation
Latest factsheet, downloadable portfolio, fund manager, AUM, plan-specific TER, NAV source, and each field's as-of date.
Folder 4
Comparison context
Mandate-aligned peer set, official benchmark, common dates, return window, drawdown, and visible history limitations.
One-page diligence note
Separate proof, interpretation, gaps, and questions
Verified
Exact strategy identified; mandate and derivative permissions read; current Risk-band located.
Interpreted
The hybrid long-short design may behave differently from both a conventional hybrid fund and a long-only equity fund.
Missing
Latest plan-specific TER, current AUM, and confirmation of the post-launch notice-period position.
Ask next
Which dated document confirms the exit terms, and how should this strategy be compared on common dates?
Final rule: unresolved decision-critical evidence stays unresolved in the note. It is never silently upgraded to a pass because the rest of the profile looks complete.
Knowledge map
Terms to understand first
Exact product identity
The SIF brand, investment strategy, strategy code, plan, option, document version, and date must refer to the same product before any field can be trusted.
Mandate versus implementation
The ISID explains what a strategy may do. A later portfolio and factsheet show how the manager actually used those permissions on specific dates.
Decision-critical evidence
A fact whose absence can change eligibility, suitability, liquidity, risk, cost, or comparison. Missing evidence in these areas should pause the review.
Evidence conflict
Two apparently credible records disagree on a value, date, plan, or term. Preserve both until a newer or more exact official source resolves the difference.
Research pause
A deliberate stop while a material fact is missing, stale, or conflicting. It is a quality-control state rather than a negative view on the fund.
Suitability stop
The process ends when the strategy role is unclear, liquidity is incompatible, risk is beyond capacity, or the minimum commitment would not be genuine surplus capital.
Section 1
Write the review brief before naming a fund
State the portfolio role, holding horizon, liquidity need, loss capacity, tax questions, and maximum acceptable complexity first. This makes the evidence answer a defined question and reduces the temptation to redesign the question around a product that looks attractive.
Section 2
Lock the identity before collecting values
A SIF brand can contain several investment strategies, plans, and options. Match the strategy name, code, plan, option, ISID, SAI, addenda, and ISIN where applicable. A correct NAV attached to the wrong plan is still the wrong fact for the review.
Section 3
Read permissions and implementation separately
The ISID establishes the objective, allocation ranges, instruments, derivative limits, benchmark, and operating terms. The factsheet and downloadable portfolio reveal current implementation. A strategy may be allowed to use an instrument without holding it on the reporting date, and one snapshot cannot prove a stable process.
Section 4
Treat liquidity as a chain, not a label
Read subscription frequency, redemption frequency, notice period, applicable NAV timing, exit load, settlement timeline, interval structure, and any liquidity-management tools together. Daily NAV publication describes valuation frequency; it does not by itself promise daily dealing or immediate settlement.
Section 5
Demand dates for the operating record
Fund manager, AUM, TER, Risk-band, portfolio, and NAV can update on different schedules. Record the value date, publication date, source, locator, plan context, and review date for each field. A page-level checked date cannot prove that every field was current on that day.
Section 6
Make performance pass a common-date test
Compare compatible mandates over shared observations, use the relevant benchmark, and inspect drawdown as well as return. New SIFs may have enough data for early behaviour analysis while still lacking a complete market cycle, which sharply limits conclusions about repeatability.
Section 7
Escalate questions instead of filling gaps
When an official field is absent or sources conflict, record the unresolved question and route it to the AMC, distributor, adviser, or tax professional as appropriate. A strong diligence note distinguishes what is known, what is interpreted, and what still requires accountable human confirmation.
Research framework
The two-pass diligence method
Complete the product pass before the comparison pass. This prevents a polished return chart from hiding an unresolved product term.
- 1Write the intended portfolio role and the investor's non-negotiable constraints before opening a product page.
- 2Confirm the exact strategy identity from the final current ISID, SAI, and all later addenda.
- 3Read allocation ranges, derivative permissions, benchmark, Risk-band, dealing frequency, notice period, and exit terms as one product design.
- 4Verify the current manager, AUM, plan-specific TER, portfolio, and NAV from field-appropriate official sources with dates.
- 5Only then compare compatible strategies on common dates and distinguish observed history from a complete market-cycle record.
- 6Finish with verified facts, interpretation, missing evidence, conflicts, and questions for the AMC or qualified professional.
Evidence table
How to read the data
Separate what a field can tell you from the official evidence needed before relying on it.
| Field | Read as | Evidence needed |
|---|---|---|
| Older official value versus newer official value | A possible update, not proof that one source is wrong. Publication date and as-of date may also differ. | Prefer the newer field-specific official record after matching strategy, plan, option, units, and effective date; preserve the superseded value in the audit trail. |
| ISID term versus later addendum | The base document may have been formally changed after launch. | Read the addendum's effective date and affected clause, then carry the amended term into the working record rather than quoting the ISID in isolation. |
| Mandate range versus portfolio weight | Permission and implementation answer different questions and can both be correct. | Keep the ISID allocation range beside the latest downloadable portfolio date; do not replace one with the other. |
| Missing value versus zero | No public observation is available, which is not the same as a reported nil value. | Show pending, unavailable, or not applicable only when the source supports that state. Never convert a blank field into zero. |
| Profile value versus directory value | A possible snapshot, caching, plan-mapping, or pipeline mismatch inside the research platform. | Compare both records to the same upstream source and date. Pause reliance until the public surfaces reconcile. |
Mistakes to avoid
Starting with returns before defining the strategy's intended portfolio role.
Treating the Rs. 10 lakh threshold as evidence that the investor can afford concentration or illiquidity.
Reading the offer-document Risk-band as current without checking the latest monthly disclosure.
Assuming daily NAV means daily redemption or immediate access to cash.
Using a maximum TER table as if it were the current plan-specific TER.
Treating a mandate's permitted instruments as proof that the latest portfolio uses them.
Comparing short histories on different dates and presenting the result as manager skill.
Allowing one strong data field to compensate for a missing decision-critical field.
Two-minute recap
What should stay with you
- 1
Product identity must be exact before a value can be correct.
- 2
Mandate permissions and current portfolio implementation are separate evidence layers.
- 3
Risk, liquidity, costs, and fit can stop the process before performance matters.
- 4
Every current field needs its own source, plan context, and date.
- 5
Continue, pause, and stop are research states, never investment recommendations.
Practical checklist
Before you rely on this topic
Write the intended portfolio role and investor constraints before selecting a SIF.
Match the exact strategy, code, plan, option, ISID, SAI, addenda, and ISIN where applicable.
Confirm the Rs. 10 lakh PAN-level SIF threshold and whether the capital is genuinely surplus.
Read mandate ranges, derivative permissions, scenario analysis, benchmark, and current Risk-band together.
Verify redemption frequency, notice period, exit load, applicable NAV, settlement, and interval terms.
Source manager, AUM, plan-specific TER, portfolio, and NAV separately with dates.
Reconcile profile, directory, document, and upstream-source conflicts before relying on a value.
Compare only compatible strategies over common dates and flag short histories visibly.
Record verified facts, interpretation, missing evidence, conflicts, and questions in separate boxes.
Pause or stop when a decision-critical gate remains unresolved or unsuitable.
Source trail
Where to verify next
SEBI SIF regulatory framework
Use the foundational framework for investment thresholds, permitted strategies, derivative exposure, liquidity, Risk-band, portfolio disclosure, and offer-document requirements.
SEBI ISID format circular
Confirm the prescribed application and Investment Strategy Information Document structure before treating a scheme document as complete.
Official current ISID example
See how identity, mandate, liquidity, plans, minimum investment, costs, manager, risks, disclosures, and scenario analysis are assembled in an official investment strategy document.
elitefunds document room
Open the tracked source registry and continue from the exact document behind a public field.
How to use elitefunds
Place this due-diligence article inside the wider research journey from learning and discovery to comparison and a review-ready question sheet.
Continue this pathway
Related SIF guides
Source quality / 14 min read
How to read a SIF ISID and source documents
A visual guide to reading the ISID, SAI, addenda, factsheets, portfolios, Strategy Summary Documents, and field-level disclosures as one dated evidence chain.
Source quality / 5 min read
How to read SIF NAV freshness
Understand the difference between daily NAV disclosures, dated factsheet NAVs, and unavailable NAV data.
Source quality / 15 min read
How to read a SIF portfolio disclosure
A visual investor guide to capital allocation, derivative exposure, concentration, reporting dates, and changes between SIF portfolio snapshots.